Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
CG Oncology, Inc. (NASDAQ: CGON)
CGON Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
92.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
47.30%
CGON Stock Analysis
CGON
PE Ratio:
CGON
PEG Ratio:
Not Available
CGON
Forward EPS Growth (12 month):
0.00%
CGON
PS Ratio:
946.6
CGON
PSG Ratio:
2.4
CGON
Forward Revenue Growth (12 month):
400.00%
CGON Articles
No data was found